論説

Addressing the Innovation Divide: Imbalanced innovation

Addressing the Innovation Divide: Imbalanced innovation

Europe is getting a "free ride" on US lab coattails where pharmaceutical research and development is concerned.

  • min read

論説

Addressing the Innovation Divide: Imbalanced innovation
en

Europe is getting a "free ride" on US lab coattails where pharmaceutical research and development is concerned. That's the argument being made by US government and business leaders. They complain that pharmaceutical R&D spending has largely shifted to the US, where Americans pay the lion's share of drug development costs. Meanwhile, they argue, consumers in Europe's largest markets enjoy the fruits of that investment-at prices 25-35% lower than those Americans pay. The debate on this issue has grown contentious. Americans charge that Europeans underpay for drugs by imposing onerous regulations on drugmakers that keep prices and utilization artificially low. Europeans retort that Americans overpay for expensive, marginally valuable medicines, thereby funding excessive industry marketing efforts.

Tags

お気軽にご連絡下さい

私達は、グローバルに活躍する経営者が抱える最重要経営課題に対して、厳しい競争環境の中でも成長し続け、「結果」を出すために支援しています。